Showing results (11-20 of 438) with videos related to
Sort By:
Pageof 44
Frontiers in Neuroanatomy|November 24, 2025
Developmental and adult expression of the Meis2 transcription factor in the central nervous system of Xenopus laevis: a developmental and evolutive analysisRuth Morona, Ana Martinez, Nerea MorenoExpert Opinion on Therapeutic Targets|February 19, 2020
Serum- and glucocorticoid-induced kinase 1, a new therapeutic target for autophagy modulation in chronic diseasesInés Maestro, Patricia Boya, Ana MartinezWMJ : Official Publication of the State Medical Society of Wisconsin|February 1, 2013
Promoting healthy food consumption: a review of state-level policies to improve access to fruits and vegetablesCarlyn Hood, Ana Martinez-Donate, Amy MeinenPreventing Chronic Disease|June 19, 2015
Parental Practices and Attitudes Related to Smoke-Free Rules in Homes, Cars, and Outdoor Playgrounds in US Households With Underage Children and Smokers, 2010-2011Xiao Zhang, Ana Martinez-Donate, Natalie RhoadsMini Reviews in Medicinal Chemistry|October 8, 2003
AMPA glutamate receptors and neuropathic painSusana Morales-Alcelay, Laura Rubio, Ana MartinezCurrent Topics in Medicinal Chemistry|August 13, 2013
Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's diseaseAna Martinez, Daniel I Perez, Carmen GilMedicinal Research Reviews|June 26, 2010
Protein kinases CK1 and CK2 as new targets for neurodegenerative diseasesDaniel I Perez, Carmen Gil, Ana MartinezCurrent Topics in Medicinal Chemistry|April 27, 2016
Enhancing cAMP Levels as Strategy for the Treatment of Neuropsychiatric DisordersAna M Garcia, Ana Martinez, Carmen GilExpert Review of Proteomics|April 6, 2019
Proteotyping pluripotency with mass spectrometryCristina Sayago, Ana Martinez-Val, Javier MunozInternational Journal of Alzheimer'S Disease|July 16, 2011
Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatmentAna Martinez, Carmen Gil, Daniel I PerezPageof 44